{"id":1124,"date":"2019-05-24T16:49:47","date_gmt":"2019-05-24T08:49:47","guid":{"rendered":"http:\/\/www.bioactivescreeninglibrary.com\/?p=1124"},"modified":"2022-01-07T10:53:22","modified_gmt":"2022-01-07T02:53:22","slug":"splice-variants-retention-exons-ring-finger-important-protein-interactions","status":"publish","type":"post","link":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/2019\/05\/24\/splice-variants-retention-exons-ring-finger-important-protein-interactions\/","title":{"rendered":"Splice variants is the retention of exons which contains a RING finger important for protein interactions"},"content":{"rendered":"<p>Although the various PML isoforms may have related functions due to the retention of the functional RBCC domain, it is coming to light that <a href=\"http:\/\/www.abmole.com\/products\/3-4-5-trimethoxyphenylacetic-acid.html\">3,4,5-Trimethoxyphenylacetic acid<\/a> isoform-specific functions exist as in the example of PML III in centrosome amplification. More recently, a cytoplasmic isoform of PML has been described as having a novel function in modulating TGFb signaling. Thus, an intriguing <a href=\"http:\/\/www.abmole.com\/products\/dexrazoxane-hydrochloride.html\">Dexrazoxane hydrochloride<\/a> possibility is that the apparent re-localization of PML during viral infection may, in part, reflect the expression of a cytoplasmicspecific PML isoform. One of the best-characterized viral proteins known to disrupt PML NBs and effect PML localization is the multifunctional infected cell protein 0 of HSV-1. Expression of ICP0 initiates immediately upon lytic infection and plays a key role in the transactivation of viral and cellular genes. ICP0-deficient mutants are defective for growth at low multiplicities of infection in cell culture, and are attenuated and fail to efficiently reactivate from latent infection in cell culture and in animals. Interestingly, depletion of PML can partially complement the defects of an ICP0-null mutant virus. ICP0 localizes near or at PML NBs early in infection and appears to facilitate the dispersal of nuclear PML and the proteosome-dependent degradation of high molecular weight PML isoforms. Some PML isoforms, however, have been observed to be recruited to viral replication compartments, and PML has been observed in the cytoplasm following PML NB disruption indicating that not all PML is degraded immediately upon infection Up to this point it has been generally assumed that PML found in the cytoplasm of infected cells is derived from nuclear PML. In this study, we characterize a unique low molecular weight isoform <img src=\"http:\/\/www.abmole.com\/upload\/structure\/Betrixaban-chemical-structure.gif\" align=\"right\" width=\"222\" style=\"padding:10px;\"\/>of PML, PML Ib, which is not only inducible by IFNc, but is expressed in cells infected with HSV-1. We show that PML Ib localizes to the cytoplasm and demonstrate that the cytoplasmic PML Ib isoform alone is capable of promoting a cellular resistance to viral infection. Surprisingly, we find that the cytoplasmic PML Ib isoform can suppress HSV-1 replication via an ICP0-dependent mechanism. Our data indicate that PML Ib sequesters ICP0 in the cytoplasm which limits viral protein accumulation and replication. We subsequently demonstrated that PML Ib primarily localizes to discrete dots in the cytoplasm and near or at the nuclear membrane. PML Ib not only showed a predominant cytoplasmic localization, it also significantly effected the localization of the PMLI isoform raising the intriguing possibility that cPMLD5&#038;6 may also effect the localization of predominantly nuclear PML isoforms during viral infection. Whether the shift in PML isoform transcript levels during HSV-1 infection can perpetuate the transformation in PML localization pattern remains to be determined. However, we have also observed that unlike PML isoforms I-VI, the protein product of PML Ib is not subject to modification by SUMOI. Thus, is it also possible that this isoform is spared from ICP0 induced degradation of SUMOylated PML isoforms. Interestingly, cytoplasmic PML dots similar to the staining pattern for PML Ib have been identified in the G1 phase of the cell cycle. Furthermore, HSV-1 infection is known to arrest cells in G1. Thus, it will be very interesting to determine the identity of the PML isoform responsible for the cytoplasmic bodies generated in G1. It is also important to note that HSV-1 infection results in the inhibition mRNA splicing early in infection largely through the action of the UL 54 gene product ICP27.. Like ICP0, ICP27 also regulates viral gene expression and can shuttle between the nucleus and cytoplasm.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Although the various PML isoforms may have related functions due to the retention of the functional RBCC domain, it is coming to light that 3,4,5-Trimethoxyphenylacetic acid isoform-specific functions exist as in the example of PML III in centrosome amplification. More recently, a cytoplasmic isoform of PML has been described as having a novel function in &hellip; <a href=\"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/2019\/05\/24\/splice-variants-retention-exons-ring-finger-important-protein-interactions\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Splice variants is the retention of exons which contains a RING finger important for protein interactions&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1124"}],"collection":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/comments?post=1124"}],"version-history":[{"count":1,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1124\/revisions"}],"predecessor-version":[{"id":1125,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1124\/revisions\/1125"}],"wp:attachment":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/media?parent=1124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/categories?post=1124"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/tags?post=1124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}